Evidence map›Paper›PMID 11504918›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2001

CmC(A/T)GG DNA methylation in mature B cell lymphoma gene silencing.

C S Malone, M D Miner, J R Doerr, J P Jackson, S E Jacobsen, R Wall, M Teitell

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. International journal of molecular sciences · 2023
    Article
  6. Review
  7. Combined loss of function of two different loci of miR-15/16 drives the pathogenesis of acute myeloid leukemia.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Cancer-specific methylation in the BRCA1 promoter in sporadic breast tumours.Medical oncology (Northwood, London, England) · 2011
    Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

C S MaloneDepartment of Microbiology and Immunology, Jonsson Comprehensive Cancer Center, University of California, Center for the Health Sciences, Los Angeles, CA 90095, USA.
M D Miner
J R Doerr
J P Jackson
S E Jacobsen
R Wall
M Teitell
UCLA Jonsson Comprehensive Cancer CenterEmory University Hospital · US

Funding

TUMOR CELL SURFACES AND CHROMOSOMEST32CA009056 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Gay M Crooks, David A. Nathanson · 1985 to 2026
$10.5M
NOVEL MECHANISMS IN B CELL LEUKEMOGENESISR01CA085841 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WALL, RANDOLPH · 2001 to 2005
$1.3M
GENES INVOLVED IN AIDS LYMPHOMAGENESISK08CA074929 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TEITELL, MICHAEL A · 1998 to 2002
$256k
NCI NIH HHS CA74929NCI NIH HHS CA85841NCI NIH HHS R01 CA085841NCI NIH HHS T32 CA009056NCI NIH HHS T32CA09056
6 · The paper itself

Abstract

DNA methylation has been linked to gene silencing in cancer. Primary effusion lymphoma (PEL) and myeloma are lymphoid malignancies that arise from terminally differentiated B cells. Interestingly, PEL do not express immunoglobulins or most B lineage-specific genes. The B cell-specific B29 (Igbeta/CD79b) gene is silenced in PEL and some myelomas but is expressed in other normal and malignant B cells. B29 expression was reactivated in PEL by demethylating and histone deacetylase inhibiting treatments. Bisulfite sequencing revealed two types of DNA methylation in silenced B29 promoters: at conventional CpG and at CC(A/T)GG B29 promoter sites. The pattern of methylated CpG ((m)CpG) and C(m)C(A/T)GG B29 promoter methylation observed was similar to that recently reported for epigenetic silencing of an integrated retrovirus. Methylation of C(m)C(A/T)GG sites in the B29 promoter significantly repressed in vivo transcriptional activity. Also, methylation of a central conserved C(m)CTGG B29 promoter site blocked the binding of early B cell factor. This methylated motif formed DNA-protein complexes with nuclear extracts from all cell types examined. Therefore, C(m)C(A/T)GG methylation may represent an important type of epigenetic marker on mammalian DNA that impacts transcription by altering DNA-protein complex formation.

Indexed as

DNA MethylationGene SilencingAntigens, CDBase SequenceCD79 AntigensDNA-Binding ProteinsDNA, NeoplasmDNA PrimersLymphoma, B-CellMacromolecular SubstancesNeoplasm ProteinsPromoter Regions, GeneticTrans-ActivatorsAntigens, CDCD79 AntigensDNA-Binding ProteinsDNA, NeoplasmDNA PrimersMacromolecular SubstancesNeoplasm ProteinsTrans-Activators

Identifiers

PMID11504918
PMCPMC56973
OpenAlexW1973222089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.